The uncertain times brought on by the COVID-19 pandemic have affected businesses worldwide, and several sectors of medtech industry are projecting hits to their bottom lines. A number of companies have announced decisions to withdraw financial guidance, cut hours and/or staff, among other major business decisions. Initial impacts of the global pandemic on Wall Street […]
Natus Medical stock takes a hit amid lower 2020 outlook
Natus Medical (NSDQ:NTUS) shares dipped today after the company lowered its 2020 sales guidance — even as it reported Q4 results met or slightly beat The Street. The Pleasanton, Calif.-based maker of monitoring and diagnostics for newborns posted profits of $3.2 million, or 10¢ per share, on sales of $131.8 million for the three months ended […]
Natus Medical issues field safety notice for snap electrode leads
Natus Medical (NSDQ:NTUS) issued an urgent field safety notice to warn users of an incompatible electrode lead connector in gold cup electrodes and snap electrode leads. The affected components are used for audiological, neurological or vestibular testing. The devices include cables that may be red, orange, yellow, green, blue, brown, black or white, according to the […]
NATUS misses Q3 expectations on The Street
Natus Medical (NSDQ:NTUS) recently reported third-quarter numbers that missed expectations on earnings and sales. The Pleasanton, Calif.-based company continued in the black for the three months ended Sept. 30, posting profits of $8.5 million, or 25¢ per share, on sales of $123.5 million, a -5.4% top-line slip. Adjusted to exclude one-time items, earnings per share were […]
Natus Medical gains on Q3 swing to black
Natus Medical (NSDQ:NTUS) swung from red to black with its third-quarter results and raised its earnings outlook for the rest of the year, sending its share price up on Wall Street. The Pleasanton, Calif.-based company posted profits of $8.5 million, or 25¢ per share, on sales of $123.5 million for the three months ended Sept. […]
Natus beats with Q2 numbers, swaps tickers
Natus Medical (NSDQ:NTUS) yesterday reported second-quarter numbers that beat expectations and changed its ticker symbol to reflect its shift from neonatal to central nervous and sensory disorder devices. The Pleasanton, Calif.-based company swung to black for the three months ended June 30, posting profits of $4.2 million, or 12¢ per share, on sales of $125.5 […]
Natus Medical shares slide on earnings restatement
Shares in Natus Medical (NSDQ:BABY) took a hit today after the medical device maker restated its first-quarter earnings after discovering an accounting error. Last month the Pleasanton, Calif.-based company posted losses of approximately -$24.8 million, or -74¢ per share, on sales of approximately $114.8 million for the three months ended March 31, seeing losses grow 687% while […]
Natus shares rise on Street-topping Q1
Shares in Natus Medical (NSDQ:BABY) have risen slightly in after hours trading after the medical device maker posted first quarter earnings that topped expectations on Wall Street. The Pleasanton, Calif.-based company posted losses of approximately $24.8 million, or 74¢ per share, on sales of approximately $114.8 million for the three months ended March 31, seeing losses […]
Natus Medical deals Medix division to employees
Natus Medical (NSDQ:BABY) said yesterday that it inked a deal to sell its subsidiary Medix Medical Devices in an employee-led buyout. In the sale, Pleasanton, Calif.-based Natus Medical said it is offloading the Medix line of products including incubators and warmers. Natus said that Medix will continue to distribute the Medix products as well as the […]
JenaValve names Kilcoyne as CEO | Personnel Moves – January 15, 2019
JenaValve Technology said today that it named former ReVision Optics prez & CEO John Kilcoyne as its new chief executive officer, effective immediately, replacing Dr. Victoria Carr-Brendell, who has taken up an executive leadership position with Sonova Holding AG (SIX:SOON). Prior to his time at ReVision Optics, Kilcoyne served as prez & CEO at Micrus Endovascular where he […]
Natus takes a hit on Q3 misses
Investors pushed share prices down today for Natus Medical (NSDQ:BABY) after the neonatal care company missed expectations with its third-quarter results. Pleasanton, Calif.-based Natus pared its losses by -34.5% to -$5.6 million, or -17¢ per share, on sales growth of 6.5% to $130.6 million for the three months ended Sept. 30, compared with Q3 2017. […]
- 1
- 2
- 3
- …
- 5
- Next Page »
